Conference Day Two
Thursday 30th March 2023
7:30 am
Morning Registration & Refreshments
8:20 am
Chairperson Opening Remarks
Exploring Human Breast Milk & Infant Formula
8:30 am Uncovering Opportunities for Precision Nutrition in the First 1000 Days of Life
Synopsis
- Reaffirming the importance of the first 1000 days in establishing health trajectories
- Appreciating human milk as nature’s precision nutrition
- STRONG kids 2 longitudinal birth cohort for precision nutrition
9:00 am Human Milk Oligosaccharides in Infant Formula Supplementation
Synopsis
- Outlining how optimal infant nutrition is attributed to diverse bioactive components present in breast milk, such as human milk oligosaccharides (HMO), complex glycans that are abundant in human milk
- Understanding the current availability of the complex glycans that are abundant in breast milk
- Appreciating the importance of more prospective, randomized trials in infants comparing formulas with and without HMOs are still needed to evaluate the clinical effects of supplementation
9:30 am Examining Breast Milk Antibodies After COVID-19 Vaccination & Correlation with Maternal Immunization
Synopsis
- Reviewing the physiology of breast milk antibody production
- Discussing the role in passive protection to the infant
- Outlining immunoglobulin transfer
10:00 am
Morning Break & Scientific Poster Session
Synopsis
Once the formal presentations are complete, let the learning and networking continue. The poster session allows you to connect with your peers in a relaxed atmosphere and continue to forge new and existing relationships. During this session scientific posters will be presented on latest advancements in pre-clinical research
11:00 am Building Immunity Starting at Birth
Synopsis
- Outlining the importance of numerous exposures leading to distinct immune
responses largely driven by human glycoproteins and the cross-talk between
the microbiome in the gut and the immune system - Discussing how Helaina are incorporating these glycoproteins in infant formula to enhance immunological properties
- Understanding how Helaina’s product will bridge the gap between infant
formula and the immunity properties breast milk provides
Assessing Microbiome-Directed Interventions to Optimize Product Development
11:30 am Tackling Complex Healthcare Challenges with Microbiome Based Products
Synopsis
- Discussing the power in the science of EVC001, a strain used to tackle infant health issues
- Delving into the imporance in driving industry forward to have a large scale impact
- Exploring product efficacy and the ability to impact human health
12:00 pm Panel Discussion: Selecting the Optimal Bacterial Composition for Scientifically Backed Infant Microbiome Supplements
Synopsis
- How should we select bacterial candidates and/or prebiotics to support microbiome development?
- What functional tests should we conduct on bacterial strains to determine probiotic/LBP suitability?
- The benefits and challenges of developing multi-strain versus single-strain supplements.
12:30 pm
Lunch Break & Networking
Streamlining Product Development to Advance Effective & Efficient Products to Market
1:30 pm Roundtables- Regulatory Differences: Food or Pharma?
Synopsis
Take the chance to dive into discussions exploring the differing regulatory landscapes across nutritional and therapeutic products
- Approaching therapeutic applications
- Exploring global differences
2:00 pm The Power of Microbiome Based Interventions: Product Development & Commercialization Across Maternal-Infant Products
Synopsis
- Delving into case studies, practices and principles of what is required to influence a new standard of care
- Discussing the importance of the rapidly commercializing products in this industry
- Exploring the strong healthcare economic impact as a driving force
2:30 pm
Afternoon Comfort Break & Networking
2:45 pm Outlining Maternal Microbiome Directed Interventions to Improve Pregnancy & Infant Outcomes in LMIC Geographies
Synopsis
- Rethinking why new tools are needed to achieve SDG mortality reduction targets and avert increasing morbidity due to maternal and neonatal conditions
- Illuminating how the foundation plans to do this through their gut microbiome portfolio by shifting to underlying risk and moving earlier in the life course
- Navigating plans to use an experimental medicine learning structure to accelerate and localize the approach to design and apply maternal microbiome directed interventions
3:15 pm Fireside Discussion: Geographical Considerations in Future Microbiome Therapeutic & Nutritional Interventions
Synopsis
- Assessing whether geographical differences in maternal-infant microbiomes need to be considered more during product development
- Discussing regional specific microbiome interventions that are in the market
- Exploring future clinical considerations during product development